• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G0S2 通过与细胞质中的核仁蛋白相互作用抑制 K562 细胞的增殖。

G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol.

机构信息

Department of Pathology & Immunology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.

Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.

出版信息

Leuk Res. 2014 Feb;38(2):210-7. doi: 10.1016/j.leukres.2013.10.006. Epub 2013 Oct 14.

DOI:10.1016/j.leukres.2013.10.006
PMID:24183236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3946941/
Abstract

G0/G1 switch gene 2 (G0S2) is a basic protein with ill-defined function that inhibits the proliferation of hematopoietic stem cells. Herein, we show that treatment of K562 cells with 5-azacytidine (5-Aza) resulted in a 24-fold increase in G0S2 expression and a reduction in cell growth. Conversely, gene demethylation in the presence of G0S2-specific shRNA restored proliferation, further supporting an inhibitory role for G0S2 in cell proliferation. Elevated levels of G0S2 inhibited the division of K562 cells by sequestering the nucleolar phosphoprotein nucleolin in the cytosol. G0S2 inhibited the proliferation of leukemia cells in vivo in xenograft models. Collectively, our data identify a new mechanism that controls proliferation in K562 cells, suggesting a possible tumor suppressor function in leukemia cells.

摘要

G0/G1 开关基因 2(G0S2)是一种基本蛋白,其功能尚未明确,它能抑制造血干细胞的增殖。在此,我们发现用 5-氮杂胞苷(5-Aza)处理 K562 细胞,可使 G0S2 表达增加 24 倍,细胞生长减少。相反,在存在 G0S2 特异性 shRNA 的情况下进行基因去甲基化,可恢复增殖,进一步支持 G0S2 在细胞增殖中的抑制作用。G0S2 水平升高通过将核仁磷酸蛋白核仁素(nucleolin)隔离在细胞质中,抑制 K562 细胞的分裂。G0S2 在异种移植模型中抑制体内白血病细胞的增殖。总的来说,我们的数据确定了一种控制 K562 细胞增殖的新机制,提示 G0S2 在白血病细胞中可能具有肿瘤抑制功能。

相似文献

1
G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol.G0S2 通过与细胞质中的核仁蛋白相互作用抑制 K562 细胞的增殖。
Leuk Res. 2014 Feb;38(2):210-7. doi: 10.1016/j.leukres.2013.10.006. Epub 2013 Oct 14.
2
G0S2--a new player in leukemia.G0S2——白血病领域的新成员。
Leuk Res. 2014 Feb;38(2):147-8. doi: 10.1016/j.leukres.2013.11.011. Epub 2013 Nov 24.
3
The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells.细胞质蛋白 G0S2 维持造血干细胞的静止状态。
PLoS One. 2012;7(5):e38280. doi: 10.1371/journal.pone.0038280. Epub 2012 May 31.
4
G0S2 modulates homeostatic proliferation of naïve CD8⁺ T cells and inhibits oxidative phosphorylation in mitochondria.G0S2调节初始CD8⁺ T细胞的稳态增殖并抑制线粒体中的氧化磷酸化。
Immunol Cell Biol. 2015 Aug;93(7):605-15. doi: 10.1038/icb.2015.9. Epub 2015 Feb 10.
5
Genetic control of quiescence in hematopoietic stem cells.造血干细胞静止的遗传控制。
Cell Cycle. 2013 Aug 1;12(15):2376-83. doi: 10.4161/cc.25416. Epub 2013 Jun 28.
6
Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest.敲低核仁素表达可抑制神经胶质瘤的生长并诱导细胞周期停滞。
J Neurooncol. 2012 May;108(1):59-67. doi: 10.1007/s11060-012-0827-2. Epub 2012 Mar 1.
7
Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells.假定的肿瘤抑制因子G0S2或小分子抑制剂对脂肪甘油三酯脂肪酶(ATGL)的抑制作用会减弱癌细胞的生长。
Oncotarget. 2015 Sep 29;6(29):28282-95. doi: 10.18632/oncotarget.5061.
8
The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond.G0/G1转换基因2(G0S2):调控代谢及其他功能
Biochim Biophys Acta. 2013 Feb;1831(2):276-81. doi: 10.1016/j.bbalip.2012.09.016. Epub 2012 Sep 29.
9
Cyclosporin A inhibits early mRNA expression of G0/G1 switch gene 2 (G0S2) in cultured human blood mononuclear cells.环孢素A抑制培养的人血单核细胞中G0/G1转换基因2(G0S2)的早期mRNA表达。
DNA Cell Biol. 1997 Dec;16(12):1449-58. doi: 10.1089/dna.1997.16.1449.
10
G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program.G0S2通过抑制MYC调控的转录程序来抑制致癌转化。
Cancer Res. 2016 Mar 1;76(5):1204-13. doi: 10.1158/0008-5472.CAN-15-2265. Epub 2016 Feb 2.

引用本文的文献

1
A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.A2AR 介导的巨噬细胞 CXCL5 上调促进非小细胞肺癌进展通过 NETosis。
Cancer Immunol Immunother. 2024 Apr 20;73(6):108. doi: 10.1007/s00262-024-03689-3.
2
Unmasking crucial residues in adipose triglyceride lipase for coactivation with comparative gene identification-58.揭示脂肪甘油三酯脂肪酶中与比较基因识别-58共同激活的关键残基。
J Lipid Res. 2024 Jan;65(1):100491. doi: 10.1016/j.jlr.2023.100491. Epub 2023 Dec 20.
3
The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism.

本文引用的文献

1
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.CDX2 驱动的白血病发生涉及 KLF4 的抑制和 PPARγ 信号的失调。
J Clin Invest. 2013 Jan;123(1):299-314. doi: 10.1172/JCI64745. Epub 2012 Dec 3.
2
Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.伊马替尼与辛伐他汀联用对伊马替尼耐药慢性髓系白血病细胞的协同杀伤作用。
Anticancer Drugs. 2013 Jan;24(1):20-31. doi: 10.1097/CAD.0b013e32835a0fbd.
3
The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond.
白血病耐药突变的获得顺序是由每种耐药机制相关的选择适应性决定的。
Sci Rep. 2023 Aug 11;13(1):13110. doi: 10.1038/s41598-023-40279-2.
4
G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells.G0S2在雌激素受体阳性(ER+)和雌激素受体阴性(ER-)乳腺癌细胞中促进抗雌激素和促迁移反应。
Transl Oncol. 2023 Jul;33:101676. doi: 10.1016/j.tranon.2023.101676. Epub 2023 Apr 20.
5
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.G0/G1 开关基因 2(G0S2)的缺失通过破坏甘油磷脂代谢促进慢性髓系白血病(CML)的疾病进展和耐药性。
Clin Transl Med. 2022 Dec;12(12):e1146. doi: 10.1002/ctm2.1146.
6
Towards a Framework for Better Understanding of Quiescent Cancer Cells.迈向更好理解静止癌细胞的框架。
Cells. 2021 Mar 5;10(3):562. doi: 10.3390/cells10030562.
7
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.蛋白酶体26S亚基非ATP酶1(PSMD1)和3(PSMD3)通过稳定核因子κB在慢性髓性白血病中发挥致癌作用。
Oncogene. 2021 Apr;40(15):2697-2710. doi: 10.1038/s41388-021-01732-6. Epub 2021 Mar 12.
8
Bioinformatic Analysis and Biophysical Characterization Reveal Structural Disorder in G0S2 Protein.生物信息学分析和生物物理表征揭示了G0S2蛋白的结构无序性。
ACS Omega. 2020 Oct 5;5(40):25841-25847. doi: 10.1021/acsomega.0c03171. eCollection 2020 Oct 13.
9
Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response.脂肪分解抑制剂 G0S2 调节神经胶质瘤干细胞的辐射反应。
J Exp Clin Cancer Res. 2019 Apr 5;38(1):147. doi: 10.1186/s13046-019-1151-x.
10
Assessment of in vivo genotoxicity of citrated-coated silver nanoparticles via transcriptomic analysis of rabbit liver tissue.通过兔肝组织转录组分析评估柠檬酸银纳米粒子的体内遗传毒性。
Int J Nanomedicine. 2019 Jan 8;14:393-405. doi: 10.2147/IJN.S174515. eCollection 2019.
G0/G1转换基因2(G0S2):调控代谢及其他功能
Biochim Biophys Acta. 2013 Feb;1831(2):276-81. doi: 10.1016/j.bbalip.2012.09.016. Epub 2012 Sep 29.
4
DNA methylation profiling in the clinic: applications and challenges.临床 DNA 甲基化分析:应用与挑战。
Nat Rev Genet. 2012 Oct;13(10):679-92. doi: 10.1038/nrg3270. Epub 2012 Sep 4.
5
Selective elimination of leukemia stem cells: hitting a moving target.选择性清除白血病干细胞:击中移动的目标。
Cancer Lett. 2013 Sep 10;338(1):15-22. doi: 10.1016/j.canlet.2012.08.006. Epub 2012 Aug 17.
6
The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells.细胞质蛋白 G0S2 维持造血干细胞的静止状态。
PLoS One. 2012;7(5):e38280. doi: 10.1371/journal.pone.0038280. Epub 2012 May 31.
7
Chronic myeloid leukemia stem cell biology.慢性髓性白血病干细胞生物学。
Curr Hematol Malig Rep. 2012 Jun;7(2):125-32. doi: 10.1007/s11899-012-0121-6.
8
DNA methylation: superior or subordinate in the epigenetic hierarchy?DNA甲基化:在表观遗传层级中是处于上位还是下位?
Genes Cancer. 2011 Jun;2(6):607-17. doi: 10.1177/1947601910393957.
9
Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.异常的 DNA 甲基化与疾病进展、对伊马替尼的耐药性以及慢性髓性白血病患者的生存时间缩短有关。
PLoS One. 2011;6(7):e22110. doi: 10.1371/journal.pone.0022110. Epub 2011 Jul 8.
10
Mechanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1).核仁蛋白和 A+U 富含元件结合因子 1(AUF1)调控 bcl-2 mRNA 的机制。
J Biol Chem. 2010 Aug 27;285(35):27182-27191. doi: 10.1074/jbc.M109.098830. Epub 2010 Jun 22.